Travere Therapeutics, Inc. Common Stock TVTX
$63.53
+2.24%
at last close
Analyst Consensus
- Consensus Rating
- Buy (9 Buy · 2 Hold · 0 Sell)
- Average Price Target
- $63.09
- Implied Upside
- -0.7%
- Price Target Range
- $25.00 – $85.00
- Analysts (12 mo)
- 11
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-10 | Evercore ISI GroupLiisa Bayko |
Maintains | Outperform | $68 → $78 |
| 2026-08-06 | Canaccord GenuityEdward Nash |
Maintains | Buy | $62 → $70 |
| 2026-08-06 | WedbushLaura Chico |
Maintains | Outperform | $61 → $75 |
| 2026-08-05 | TD CowenTyler Van Buren |
Maintains | Buy | $60 → $75 |
| 2026-08-05 | CitigroupYigal Nochomovitz |
Maintains | Buy | $70 → $85 |
| 2026-08-05 | Evercore ISI GroupLiisa Bayko |
Maintains | Outperform | $60 → $68 |
| 2026-08-05 | GuggenheimVamil Divan |
Maintains | Buy | $65 → $75 |
| 2026-07-30 | Canaccord GenuityEdward Nash |
Maintains | Buy | $56 → $62 |
| 2026-06-25 | GuggenheimVamil Divan |
Maintains | Buy | $56 → $65 |
| 2026-06-22 | WedbushLaura Chico |
Maintains | Outperform | $55 → $61 |
| 2026-06-18 | Evercore ISI GroupLiisa Bayko |
Maintains | Outperform | $52 → $60 |
| 2026-06-15 | CitigroupYigal Nochomovitz |
Maintains | Buy | $62 → $70 |
| 2026-06-12 | Wells FargoMohit Bansal |
Maintains | Overweight | $50 → $65 |
| 2026-06-03 | CitigroupYigal Nochomovitz |
Maintains | Buy | $59 → $62 |
| 2026-06-03 | WedbushLaura Chico |
Reiterates | Outperform | $55 |
| 2026-06-02 | HC Wainwright & Co.Joseph Pantginis |
Maintains | Buy | $57 → $67 |
| 2026-05-06 | Wells FargoMohit Bansal |
Maintains | Overweight | $40 → $50 |
| 2026-05-05 | TD CowenTyler Van Buren |
Maintains | Buy | $45 → $60 |
| 2026-05-05 | CitigroupYigal Nochomovitz |
Maintains | Buy | $53 → $59 |
| 2026-05-05 | WedbushLaura Chico |
Maintains | Outperform | $53 → $55 |
| 2026-05-05 | HC Wainwright & Co.Joseph Pantginis |
Maintains | Buy | $47 → $57 |
| 2026-04-24 | GuggenheimVamil Divan |
Maintains | Buy | $54 → $56 |
| 2026-04-14 | CitigroupYigal Nochomovitz |
Maintains | Buy | $48 → $53 |
| 2026-04-14 | Canaccord GenuityEdward Nash |
Maintains | Buy | $47 → $56 |
| 2026-04-14 | WedbushLaura Chico |
Maintains | Outperform | $39 → $44 |
| 2026-04-14 | GuggenheimVamil Divan |
Maintains | Buy | $49 → $54 |
| 2026-04-14 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $47 |
| 2026-03-25 | JP MorganAnupam Rama |
Maintains | Overweight | $44 → $41 |
| 2026-02-06 | Piper SandlerAllison Bratzel |
Maintains | Neutral | $35 → $38 |
| 2025-11-28 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $47 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $63.53
- Market Cap
- $5.86 billion
- 52-Week Range
- $15.03 – $66.24
- Average Volume
- 1.54 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.